Patell: "If the risk of clots is a factor to consider in the treatment of a patient with diabetes, the agonists of the GLP-1 receiver could be a favorable option." Conclusion This study emphasizes how GLP-1 medications not only help control type 2 diabetes, but they could also offer additional protection against serious complications such as blood clots.Although more research is needed, current data provides hope to further improve diabetes and their associated risks
The most common side effects of GLP-1s are nausea, vomiting, diarrhea, and abdominal pain
The gastrointestinal side effects most commonly associated with GLP-1 medications include nausea, bloating, constipation, and diarrhea
I know it sounds impossible, but I knew there had to be a better way
NICE and MHRA guidance recommend monitoring for gastrointestinal side effects and reporting adverse reactions through the Yellow Card scheme
Your results stall and rebound easily
